MoneyWorks4Me

Indoco Remedies - Quaterly Results

24 Oct 2024 Evaluate
A decrease in the sales to Rs. 3965.30 millions was observed for the quarter ended September 2024. The sales stood at Rs. 4733.90 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 127.90 millions from Rs. 331.40 millions, a decline of -61.41% on QoQ basis.A decline of 570.70 millions was observed in the OP in the quarter ended September 2024 from 735.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3965.30 4733.90 -16.24 7979.60 8962.70 -10.97 17908.10 16666.90 7.45
Other Income 42.00 11.20 275.00 77.20 15.30 404.58 85.10 23.30 265.24
PBIDT 570.70 735.40 -22.40 1121.60 1368.60 -18.05 2664.90 2872.20 -7.22
Interest 147.70 81.00 82.35 266.50 158.80 67.82 368.20 250.30 47.10
PBDT 423.00 654.40 -35.36 855.10 1209.80 -29.32 2412.00 2621.90 -8.01
Depreciation 249.20 214.10 16.39 486.20 412.80 17.78 879.80 706.00 24.62
PBT 173.80 440.30 -60.53 368.90 797.00 -53.71 1532.20 1915.90 -20.03
TAX 45.90 108.90 -57.85 91.50 206.20 -55.63 365.80 502.30 -27.17
Deferred Tax 13.50 -6.20 -317.74 11.80 5.60 110.71 38.10 -49.70 -176.66
PAT 127.90 331.40 -61.41 277.40 590.80 -53.05 1166.40 1413.60 -17.49
Equity 184.40 184.30 0.05 184.40 184.30 0.05 184.40 184.30 0.05
PBIDTM(%) 14.39 15.53 -7.35 14.06 15.27 -7.95 14.88 17.23 -13.65
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..